Diabetes Clinical Trials in Atlanta

Showing 221-240 of 475 trials

21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

NCT03156361

Single Center, Double Blind, Active Comparator Controlled 2-Way Crossover Multiple Dose Safety, Tolerability and Efficacy Study

Type1 Diabetes Mellitus

Diasome Pharmaceuticals24 participantsStarted May 2017

Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

Evaluation of the Accuracy of an Implanted Glucose Sensor

NCT02647905

The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.

Diabetes Mellitus

Senseonics, Inc.90 participantsStarted Jan 2016

Concord, California, United States • Escondido, California, United States • Walnut Creek, California, United States +6 more locations

COMPLETEDPhase 2< 1 mile

A Study for Patients With Type 1 Diabetes

NCT01049412

Comparison of blood glucose levels in patients with Type 1 diabetes when they take a new basal insulin analog and when they take insulin glargine

Diabetes Mellitus, Type 1

Eli Lilly and Company138 participantsStarted Jan 2010

Chula Vista, California, United States • Atlanta, Georgia, United States • Idaho Falls, Idaho, United States +10 more locations

21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

Evaluation of the Accuracy of an Implanted Glucose Sensor

A Study for Patients With Type 1 Diabetes

Diabetes Trials in Other Cities

A Study in Participants With Type 2 Diabetes Mellitus

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Atlanta